decrease the need for cardiac transplantation. 53 These paradoxical responses have been
attributed to the fact that many inotropic and vasodilating agents enhance cardiac …

Approximately 50% of the patients with chronic obstructive coronary artery disease resulting
in chronic contractile dysfunction have hibernating myocardium and may benefit from …

Objectives: This study pools data from published series examining late survival with
revascularization versus medical therapy after myocardial viability testing in patients with …

The hibernating myocardium refers to resting LV dysfunction due to reduced coronary blood
flow that can be partially or completely reversed by myocardial revascularization and/or by …

Background—Recent studies indicate that MRI, after administration of gadolinium-
diethylenetriamine pentaacetic acid, can identify nonviable areas in dysfunctional …

Objectives: We conducted a randomized trial to assess the effectiveness of F-18-
fluorodeoxyglucose (FDG) positron emission tomography (PET)-assisted management in …

Objectives. This study evaluated the relative merits of the most frequently used techniques
for predicting improvement in regional contractile function after coronary revascularization in …

For many years, the functional sequelae of chronic coronary artery disease were considered
irreversible and amenable only to palliative therapy. For example, a finding of asynergy (the …

Patients with coronary artery disease (CAD) and severe left ventricular (LV) dysfunction
have a high but variable annual mortality and some may benefit from myocardial …

Background Myocardial hibernation is a condition of chronic left ventricular dysfunction
associated with severe coronary artery disease whereby significant recovery of function …